Latest Commercialization News

The US Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher program through September 2029, a move that could significantly benefit Neuren Pharmaceuticals as it advances its rare disease drug candidates.

Evolution Trustees has appointed LDR Capital as the new manager of Elanor Commercial Property Fund following the termination of previous management agreements with Elanor Asset Services.

Elanor Investors Group has ended its management role in the Elanor Commercial Property Fund following a securityholder vote, receiving $8.5 million in compensation as the fund transitions to new leadership.

Elanor Commercial Property Fund members have voted to replace Elanor Funds Management Limited with Evolution Trustees Limited as the responsible entity, marking a significant governance shift now officially recorded by ASIC.

ADX Energy has revealed a significant technical update on its Welchau appraisal permit in Austria, highlighting a connected petroleum system with 18 million barrels of prospective light oil and 125 billion cubic feet of gas condensate resources.

Cauldron Energy’s latest groundwater analysis at the Yanrey Uranium Project reveals low chloride and sulphate levels, affirming the site’s suitability for environmentally friendly in situ recovery uranium mining. This milestone supports the company’s plans to expand resources and advance towards production.

Botala Energy has raised A$3 million through an oversubscribed placement to fully fund drilling and flow testing at its Serowe coal bed methane project this quarter, advancing its commercial gas ambitions.

BPM Minerals has revealed significant soil sampling results at its Forelands Gold Project in Western Australia, identifying multiple untested gold-in-soil anomalies. The company is poised to recommence reverse circulation drilling in early March 2026 to test these promising targets and extend known high-grade mineralisation.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Larvotto Resources continues to deliver robust drilling results at its Freehold prospect, revealing significant gold, antimony, and tungsten mineralisation that bolsters the Hillgrove Project’s growth outlook.

ION Video Ltd has strengthened its board with the return of its original inventor, Finbar O’Hanlon, alongside CEO Anthony Baker, as the company pivots to become foundational infrastructure for Video Superintelligence.